Larvol Delta - Comparative-the-efficacy-and-safety-of-Gosuranemab-Semorinemab-Tilavonemab-and-Zagotenemab-in-patients-with-Alzheimer39s-disease-a-systematic-review-and-network-metaanalysis-of-randomized-controlled-trials

tilavonemab (ABBV-8E12) - AbbVie

semorinemab (RG6100) - AC Immune

gosuranemab (BIIB092) - Biogen

zagotenemab (LY3303560) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/39945003

Hui Zhang; Jinping Zhang; Wenting Cai; Yan Wu; Yao Yao

Feb 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next